Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
50%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

terminated120%
completed240%
recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
completednot_applicable

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

NCT04074642
recruiting

Pressure Injuries in the Operating Room and Their Perioperative Incidence in Patients Undergoing Neurosurgery.

NCT06615271
recruitingnot_applicable

Treatment of Brain AVMs (TOBAS) Study

NCT02098252
completed

Incidence, Risk Factors and Impact of Significant Pain in Patients Undergoing Neurosurgery

NCT05264012
terminatedphase_2

Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation

NCT00659334

Clinical Trials (5)

Showing 5 of 5 trials
NCT04074642Not Applicable

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

Completed
NCT06615271

Pressure Injuries in the Operating Room and Their Perioperative Incidence in Patients Undergoing Neurosurgery.

Recruiting
NCT02098252Not Applicable

Treatment of Brain AVMs (TOBAS) Study

Recruiting
NCT05264012

Incidence, Risk Factors and Impact of Significant Pain in Patients Undergoing Neurosurgery

Completed
NCT00659334Phase 2

Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation

Terminated

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5